Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials.

Labrador-Velandia S, Alonso-Alonso ML, Alvarez-Sanchez S, González-Zamora J, Carretero-Barrio I, Pastor JC, Fernandez-Bueno I, Srivastava GK.

World J Stem Cells. 2016 Nov 26;8(11):376-383. Review.

2.

Advances in bone marrow stem cell therapy for retinal dysfunction.

Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA.

Prog Retin Eye Res. 2017 Jan;56:148-165. doi: 10.1016/j.preteyeres.2016.10.002. Epub 2016 Oct 23. Review.

PMID:
27784628
3.

The use of induced pluripotent stem cells for studying and treating optic neuropathies.

Khan S, Hung SS, Wong RC.

Curr Opin Organ Transplant. 2016 Oct;21(5):484-9. doi: 10.1097/MOT.0000000000000348.

PMID:
27517502
4.

Update on Clinical Trials in Dry Age-related Macular Degeneration.

Taskintuna I, Elsayed ME, Schatz P.

Middle East Afr J Ophthalmol. 2016 Jan-Mar;23(1):13-26. doi: 10.4103/0974-9233.173134. Review.

5.

Cell therapy for retinal disease.

Ehmann D, Shahlaee A, Ho AC.

Curr Opin Ophthalmol. 2016 May;27(3):185-90. doi: 10.1097/ICU.0000000000000254. Review.

PMID:
26859132
6.

Retinal pigment epithelium transplantation: concepts, challenges, and future prospects.

Alexander P, Thomson HA, Luff AJ, Lotery AJ.

Eye (Lond). 2015 Aug;29(8):992-1002. doi: 10.1038/eye.2015.89. Epub 2015 Jun 5. Review.

7.

An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Cheng J, Zhou ZW, Sheng HP, He LJ, Fan XW, He ZX, Sun T, Zhang X, Zhao RJ, Gu L, Cao C, Zhou SF.

Drug Des Devel Ther. 2014 Dec 17;9:33-78. doi: 10.2147/DDDT.S72892. eCollection 2015. Review.

8.

Ocular stem cells: a status update!

Dhamodaran K, Subramani M, Ponnalagu M, Shetty R, Das D.

Stem Cell Res Ther. 2014;5(2):56. Review.

9.

Update on current and future novel therapies for dry age-related macular degeneration.

Leung E, Landa G.

Expert Rev Clin Pharmacol. 2013 Sep;6(5):565-79. doi: 10.1586/17512433.2013.829645. Epub 2013 Aug 24. Review.

PMID:
23971874
10.

An update on ocular involvement in mucopolysaccharidoses.

Ganesh A, Bruwer Z, Al-Thihli K.

Curr Opin Ophthalmol. 2013 Sep;24(5):379-88. doi: 10.1097/ICU.0b013e3283644ea1. Review.

PMID:
23872816
11.

A review and update on the current status of stem cell therapy and the retina.

Ong JM, da Cruz L.

Br Med Bull. 2012 Jun;102:133-46. doi: 10.1093/bmb/lds013. Epub 2012 May 9. Review.

PMID:
22577179
12.

Stem cell therapy for retinal diseases: update.

Siqueira RC.

Stem Cell Res Ther. 2011 Dec 29;2(6):50. doi: 10.1186/scrt91. Review.

13.

Understanding retinopathy of prematurity: update on pathogenesis.

Rivera JC, Sapieha P, Joyal JS, Duhamel F, Shao Z, Sitaras N, Picard E, Zhou E, Lachapelle P, Chemtob S.

Neonatology. 2011;100(4):343-53. doi: 10.1159/000330174. Epub 2011 Oct 3. Review.

14.

[Mesenchymal stem cells: A therapeutic update].

Jorgensen C, Deschaseaux F, Planat-Benard V, Gabison E.

Med Sci (Paris). 2011 Mar;27(3):275-84. doi: 10.1051/medsci/2011273275. Epub 2011 Mar 30. French.

15.

Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California).

Lutty GA, Chan-Ling T, Phelps DL, Adamis AP, Berns KI, Chan CK, Cole CH, D'Amore PA, Das A, Deng WT, Dobson V, Flynn JT, Friedlander M, Fulton A, Good WV, Grant MB, Hansen R, Hauswirth WW, Hardy RJ, Hinton DR, Hughes S, McLeod DS, Palmer EA, Patz A, Penn JS, Raisler BJ, Repka MX, Saint-Geniez M, Shaw LC, Shima DT, Smith BT, Smith LE, Tahija SG, Tasman W, Trese MT.

Mol Vis. 2006 May 23;12:532-80.

Supplemental Content

Loading ...
Support Center